Previous 10 | Next 10 |
Achieve Life Sciences to Announce Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 8, 2019 Canada NewsWire SEATTLE and VANCOUVER, British Columbia, July 30, 2019 SEATTLE and VANCOUVER, British Columbia , July 30, 2019 /CNW/ -- Ac...
Achieve Life Sciences ( ACHV +0.5% ) has extended its collaboration with the National Institutes of Health's (NIH) National Center for Complementary and Integrative Health (NCCIH) under which the latter will fund and provide research to support additional nonclinical studies as requ...
SEATTLE and VANCOUVER, British Columbia , July 23, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company focused on nicotine addiction, today announced it has extended its strategic collaboration with the National Center for Comple...
ContraVir Pharmaceuticals (NASDAQ: CTRV ) +42% on FDA reaction to CRV431 plans. More news on: ContraVir Pharmaceuticals, Inc., Axovant Gene Therapies Ltd., Seadrill Limited, Stocks on the move, Read more ...
Achieve Life Sciences (NASDAQ: ACHV ) announces that an abstract featuring data from the Phase 2b ORCA-1 dose-selection study of cytisinicline for smoking cessation has been accepted for oral presentation at the Society for Research on Nicotine & Tobacco Europe (SRNT-E) Annua...
SEATTLE, Wash. and VANCOUVER, British Columbia , June 21, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company focused on nicotine addiction, today announced that an abstract featuring data from the Phase 2b ORCA-1 trial has bee...
Gainers: Jaguar Health (NASDAQ: JAGX ) +60% . ContraVir Pharmaceuticals (NASDAQ: CTRV ) +40% . TORM (NASDAQ: TRMD ) +20% . Rekor Systems, Inc. (REKR) +17% . Enzo Biochem, Inc. (NYSE: ENZ ) +17% . Oxbridge Re Holdings (NASDAQ: OXBR ) +16% . Tenax Therapeutics (NASDAQ: TENX ) +1...
CymaBay Therapeutics (NASDAQ: CBAY ) -45% on disappointing data on NASH candidate seladelpar. More news on: CymaBay Therapeutics, Inc., Achieve Life Sciences, Inc., Beyond Meat, Inc., Stocks on the move, Read more ...
Achieve Life Sciences (NASDAQ: ACHV ) is up 16% premarket on robust volume in response to results from the Phase 2 ORCA-1 dose-selection study of cytisinicline for smoking cessation. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Cons...
3.0 mg, 3 times daily selected as dose for future clinical development SEATTLE and VANCOUVER, British Columbia , June 11, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company focused on nicotine addiction, today announced posi...
News, Short Squeeze, Breakout and More Instantly...
Achieve Life Sciences Inc. Company Name:
ACHV Stock Symbol:
NASDAQ Market:
Achieve Life Sciences Inc. Website:
– Two New Independent Directors, Stuart Duty and Andrew Saik, Appointed – Third New Independent Director to Be Appointed to Board in Near Term MONTREAL and CHARLOTTE, N.C., July 15, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) (...
SEATTLE and VANCOUVER, British Columbia, July 09, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that...
SEATTLE and VANCOUVER, British Columbia, July 01, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, announced that the c...